SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026)
SS Innovations International's (SSII) quarterly Cash from Investing Activities came in at -$160871.0 in Q2 2026, up 49.2% year-over-year from -$107825.5 in Q2 2025, and down 196.87% quarter-over-quarter from -$54189.0 in Q1 2026.
Powered by 
Analysis
SS Innovations International (SSII) Cash from Investing Activities (2017 - 2026) Analysis & Trends
SS Innovations International has disclosed Cash from Investing Activities across 10 years of filings, most recently posting -$160871.0 for Q2 2026.
- In Q2 2026, Cash from Investing Activities rose 49.2% year-over-year to -$160871.0; the TTM figure through Jun 2026 stood at -$2.7 million (down 791.55% YoY), while the FY2025 annual figure was -$3.7 million, down 453.16% from the prior year.
- Cash from Investing Activities came in at -$160871.0 for Q2 2026 at SS Innovations International, down from -$54189.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $1.7 million in Q3 2024 to a low of -$2.1 million in Q2 2024.
- Average Cash from Investing Activities over 5 years is -$320617.8, with a median of -$132392.5 recorded in 2022.
- Year-over-year, Cash from Investing Activities slumped 6329.8% in 2023 and surged 872.1% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$137530.0 in 2022, then rose by 7.48% to -$127249.0 in 2023, then climbed by 1.66% to -$125142.0 in 2024, then slumped by 1270.07% to -$1.7 million in 2025, then surged by 90.62% to -$160871.0 in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$160871.0 in Q2 2026, -$54189.0 in Q1 2026, and -$1.7 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | SS Innovations International | 650.44 Mn | 628.15 Mn | 7.10 Mn | -160,871.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -160,871.00 |
| Mar 31, 2026 | -54,189.00 |
| Dec 31, 2025 | -1.71 Mn |
| Sep 30, 2025 | -755,075.00 |
| Jun 30, 2025 | -316,648.00 |
| Mar 31, 2025 | -872,804.00 |
| Dec 31, 2024 | -125,142.00 |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | -2.11 Mn |
| Mar 31, 2024 | -127,255.00 |
| Dec 31, 2023 | -127,249.00 |
| Sep 30, 2023 | -220,542.00 |
| Jun 30, 2023 | -33,655.00 |
| Mar 31, 2023 | -71,881.00 |
| Dec 31, 2022 | -137,530.00 |
| Sep 30, 2022 | -3,430.00 |
| Dec 31, 2021 | 26,000.00 |
| Dec 31, 2020 | -40,000.00 |
| Mar 31, 2020 | -4,000.00 |
| Dec 31, 2019 | 25,000.00 |